Publications by authors named "Jason Dare"

Claim this Profile
S
Safety and effectiveness of abatacept in juvenile idiopathic arthritis: results from the PRINTO/PRCSG registry.
Daniel J Lovell, Nikolay Tzaribachev, Michael Henrickson, Gabriele Simonini, Thomas A Griffin, Jason Dare

Rheumatology (Oxford)· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Absence of Association Between Abatacept Exposure and Initial Infection in Patients With Juvenile Idiopathic Arthritis.
Nicolino Ruperto, Hermine I Brunner, Nikolay Tzaribachev, Gabriel Vega-Cornejo, Ingrid Louw, Jason Dare

J Rheumatol· July 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety and Effectiveness of Adalimumab in Patients With Polyarticular Course of Juvenile Idiopathic Arthritis: STRIVE Registry Seven-Year Interim Results.
Hermine I Brunner, Kabita Nanda, Mary Toth, Ivan Foeldvari, John Bohnsack, Jason A Dare

Arthritis Care Res (Hoboken)· October 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Distinct interferon signatures and cytokine patterns define additional systemic autoinflammatory diseases.
Adriana A de Jesus, Yangfeng Hou, Stephen Brooks, Louise Malle, Angelique Biancotto, Jason Dare

J Clin Invest· April 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Serum S100A8/A9 and S100A12 Levels in Children With Polyarticular Forms of Juvenile Idiopathic Arthritis: Relationship to Maintenance of Clinically Inactive Disease During Anti-Tumor Necrosis Factor Therapy and Occurrence of Disease Flare After Discontinuation of Therapy.
Claas H Hinze, Dirk Foell, Anne L Johnson, Steven J Spalding, Beth S Gottlieb, Jason A Dare

Arthritis Rheumatol· March 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Risk, Timing, and Predictors of Disease Flare After Discontinuation of Anti-Tumor Necrosis Factor Therapy in Children With Polyarticular Forms of Juvenile Idiopathic Arthritis With Clinically Inactive Disease.
Daniel J Lovell, Anne L Johnson, Bin Huang, Beth S Gottlieb, Paula W Morris, Jason A Dare

Arthritis Rheumatol· September 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
J
JAK1/2 inhibition with baricitinib in the treatment of autoinflammatory interferonopathies.
Gina A Montealegre Sanchez, Adam Reinhardt, Suzanne Ramsey, Helmut Wittkowski, Philip J Hashkes, Jason A Dare

J Clin Invest· July 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A 6-month, multicenter, open-label study of fixed dose naproxen/esomeprazole in adolescent patients with juvenile idiopathic arthritis.
Daniel J Lovell, Jason A Dare, Megan Francis-Sedlak, Julie Ball, Brian D LaMoreaux

Pediatr Rheumatol Online J· June 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Transcriptional profiles of JIA patient blood with subsequent poor response to methotrexate.
Halima Moncrieffe, Mark F Bennett, Monica Tsoras, Lorie K Luyrink, Anne L Johnson, Jason Dare

Rheumatology (Oxford)· September 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Proceedings of the 2016 Childhood Arthritis and Rheumatology Research Alliance (CARRA) Scientific Meeting : Toronto, Canada. 14-17 April 2016.
Lampros Fotis, Nur Shaikh, Kevin Baszis, Anthony French, Phillip Tarr, Jason Dare

Pediatr Rheumatol Online J· July 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
J
Juvenile dermatomyositis as a paraneoplastic phenomenon: an update.
Paula Morris, Jason Dare

J Pediatr Hematol Oncol· April 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Reintroduction of etanercept during treatment of cutaneous Mycobacterium marinum infection in a patient with ankylosing spondylitis.
Jason A Dare, Shormi Jahan, Kim Hiatt, Karina D Torralba

Arthritis Rheum· May 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis